Advanced Proteome Therapeutics Corporation’s (APC) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Advanced Proteome Therapeutics Corporation is a Sell.

Advanced Proteome Therapeutics Corporation’s (APC) 20-Day exponential moving average is 0.02, while Advanced Proteome Therapeutics Corporation’s (APC) share price is <C$0.1, making it a Sell.

Advanced Proteome Therapeutics Corporation’s (APC) 50-Day exponential moving average is 0.03, while Advanced Proteome Therapeutics Corporation’s (APC) share price is <C$0.1, making it a Sell.

Advanced Proteome Therapeutics (APC) Pivot Points

May 17, 2024, 07:22 PM

Classic

0.02

Fibonacci

0.02

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Advanced Proteome Therapeutics (APC) Moving Averages

May 17, 2024, 07:22 PM

MA5

0.02Buy

0.02Sell

MA10

0.02Sell

MA20

0.02Buy

0.02Sell

MA50

0.02Sell

0.03Sell

MA100

0.04Sell

0.03Sell

MA200

0.05Sell

Advanced Proteome Therapeutics Corporation’s (APC) 10-Day exponential moving average is 0.02, while Advanced Proteome Therapeutics Corporation’s (APC) share price is <C$0.1, making it a Sell.

Advanced Proteome Therapeutics Corporation’s (APC) 100-Day exponential moving average is 0.03, while Advanced Proteome Therapeutics Corporation’s (APC) share price is <C$0.1, making it a Sell.

Advanced Proteome Therapeutics Corporation’s (APC) stock price is <C$0.1 and Advanced Proteome Therapeutics Corporation’s (APC) 50-day simple moving average is 0.02, creating a Sell signal.

Advanced Proteome Therapeutics Corporation’s (APC) stock price is <C$0.1 and Advanced Proteome Therapeutics Corporation’s (APC) 100-day simple moving average is 0.04, creating a Sell signal.

Advanced Proteome Therapeutics Corporation’s (APC) stock price is <C$0.1 and Advanced Proteome Therapeutics Corporation’s (APC) 200-day simple moving average is 0.05, creating a Sell signal.

Advanced Proteome Therapeutics (APC) Technical Indicators

May 17, 2024, 07:22 PM

RSI (14)

32.35

Neutral

STOCH (9,6)

22.22

Neutral

STOCHRSI (14)

38.89

Neutral

MACD (12,26)

>-0.01

Sell

ADX (14)

25.97

Neutral

Williams %R

-33.33

Buy

CCI (14)

-120.37

Buy

ATR (14)

<0.01

Ultimate Oscillator

31.63

Neutral

ROC

0.00

Advanced Proteome Therapeutics Corporation’s (APC) Relative Strength Index (RSI) is 32.35, creating a Neutral signal.

Advanced Proteome Therapeutics Corporation’s (APC) Trend Strength Indicator (ADX) is 25.97, creating a Neutral signal.

Advanced Proteome Therapeutics Corporation’s (APC) Commodity Channel Index (CCI) is -120.37, creating a Buy signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is APC a Buy, Hold, or Sell?

Based on APC’s technical indicators, APC is a Sell.

What is APC’s RSI (14)?

APC’s RSI (14) is 32.35, which suggests APC is a Neutral.

What is APC’s MACD?

APC’s MACD is >-0.01, which suggests APC is a Sell.

What is APC’s 5-day moving average?

APC’s 5-day moving average is 0.02, which suggests APC is a Buy.

What is APC’s 20-day moving average?

APC 20-day moving average is 0.02, which suggests APC is a Buy.

What is APC’s 50-day moving average?

APC’s 50-day moving average is 0.02, which suggests APC is a Sell.

What is APC’s 200-day moving average?

APC’s 200-day moving average is 0.05, which suggests APC is a Sell.

What is APC’s Williams % R (14)?

APC’s Williams % R (14) is -33.33, which suggests APC is a Buy.

What is APC’s CCI (14)?

APC’s CCI (14) is -120.37, which suggests APC is a Buy.

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing